Related references
Note: Only part of the references are listed.Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
Rebecca E. Schweppe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells
Hua-Qin Wang et al.
ENDOCRINOLOGY (2007)
Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress - Relevance to Parkinson disease
Noriyuki Yamamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells.
W Zou et al.
CLINICAL CANCER RESEARCH (2006)
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
P Perez-Galan et al.
BLOOD (2006)
Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor α -: Related apoptosis-inducing ligand/anticancer drug combinations
O Meurette et al.
CLINICAL CANCER RESEARCH (2005)
The proteasome: A suitable antineoplastic target
J Adams
NATURE REVIEWS CANCER (2004)
Genetically altered mice to evaluate glutathione homeostasis in health and disease
TP Dalton et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Proteasome inhibitor PS-341 induces a apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells
A Fribley et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib
CR Yu et al.
EXPERIMENTAL CELL RESEARCH (2004)
Proteasome inhibitors up-regulate haem oxygenase-1 gene expression:: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-κB (nuclear factor κB) inhibition
WT Wu et al.
BIOCHEMICAL JOURNAL (2004)
Strategies for reversing drug resistance
T Fojo et al.
ONCOGENE (2003)
Catalase is regulated by ubiquitination and proteosornal degradation. Role of the c-Abl and Arg tyrosine kinases
C Cao et al.
BIOCHEMISTRY (2003)
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells
YH Ling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The importance of glutathione in human disease
DM Townsend et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
The proteasome: structure, function, and role in the cell
J Adams
CANCER TREATMENT REVIEWS (2003)
Induction and regulation of hepatocyte apoptosis by oxidative stress
MJ Czaja
ANTIOXIDANTS & REDOX SIGNALING (2002)
Mitochondrial reactive oxygen species in cell death signaling
C Fleury et al.
BIOCHIMIE (2002)
Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes
CL Hammond et al.
JOURNAL OF HEPATOLOGY (2001)
Caspases - controlling intracellular signals by protease zymogen activation
HR Stennicke et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Redox regulatory mechanisms of cellular signal transduction
SP Gabbita et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Ebselen induces apoptosis in HepG2 cells through rapid depletion of intracellular thiols
CF Yang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Share Paper
